Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
2021 · Journal for ImmunoTherapy of Cancer · 92 citations
https://doi.org/10.1136/jitc-2020-001696
Y
Yi Que
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
140
Papers
891
Citations
15
h-index
25
i10-index
Yi Que is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research. The author has an h-index of 15, co-authored 119 publications.
Papers by this author
worksPreoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma
2015 · BMC Cancer · 64 citations
https://doi.org/10.1186/s12885-015-1654-6
Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma
2023 · Cell Reports Medicine · 44 citations
https://doi.org/10.1016/j.xcrm.2023.101133
KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axis
2022 · Cell Death and Disease · 27 citations
https://doi.org/10.1038/s41419-022-04800-1
FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcoma
2024 · Cancer Gene Therapy · 21 citations
https://doi.org/10.1038/s41417-024-00823-2
Safety and clinical efficacy of sintilimab (anti-PD-1) in pediatric patients with advanced or recurrent malignancies in a phase I study
2023 · Signal Transduction and Targeted Therapy · 13 citations
https://doi.org/10.1038/s41392-023-01636-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat